Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

KRYS

Krystal Biotech (KRYS)

Krystal Biotech Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:KRYS
일자시간출처헤드라인심볼기업
2024/06/0807:09PR Newswire (US)KKR, CrowdStrike Holdings and GoDaddy Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600NASDAQ:KRYSKrystal Biotech Inc
2024/06/0520:00GlobeNewswire Inc.Krystal Biotech to Present at Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:KRYSKrystal Biotech Inc
2024/05/2205:38Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRYSKrystal Biotech Inc
2024/05/1520:00GlobeNewswire Inc.Krystal Biotech to Present at the American Thoracic Society 2024 International ConferenceNASDAQ:KRYSKrystal Biotech Inc
2024/05/0820:00GlobeNewswire Inc.Krystal Biotech to Present at BofA Securities 2024 Health Care ConferenceNASDAQ:KRYSKrystal Biotech Inc
2024/05/0621:17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:KRYSKrystal Biotech Inc
2024/05/0621:09IH Market NewsIndex Futures Point to Strong Monday Opening, Building on Last Week’s Gains; Oil Prices RiseNASDAQ:KRYSKrystal Biotech Inc
2024/05/0621:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRYSKrystal Biotech Inc
2024/05/0621:00GlobeNewswire Inc.Krystal Biotech Announces First Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ:KRYSKrystal Biotech Inc
2024/05/0220:00GlobeNewswire Inc.Krystal Biotech to Present at the Association for Research in Vision and Ophthalmology 2024 Annual MeetingNASDAQ:KRYSKrystal Biotech Inc
2024/04/2620:00GlobeNewswire Inc.Krystal Biotech to Report First Quarter 2024 Financial Results on May 6, 2024NASDAQ:KRYSKrystal Biotech Inc
2024/04/2220:00GlobeNewswire Inc.Krystal Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of Inhaled KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors of the LungNASDAQ:KRYSKrystal Biotech Inc
2024/04/0420:00GlobeNewswire Inc.Krystal Biotech to Present at the American Association for Cancer Research 2024 Annual MeetingNASDAQ:KRYSKrystal Biotech Inc
2024/03/0210:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRYSKrystal Biotech Inc
2024/03/0210:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRYSKrystal Biotech Inc
2024/02/2911:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRYSKrystal Biotech Inc
2024/02/2821:00GlobeNewswire Inc.Krystal Biotech to Present at TD Cowen 44th Annual Health Care ConferenceNASDAQ:KRYSKrystal Biotech Inc
2024/02/2703:35Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:KRYSKrystal Biotech Inc
2024/02/2622:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRYSKrystal Biotech Inc
2024/02/2622:00GlobeNewswire Inc.Krystal Biotech Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdatesNASDAQ:KRYSKrystal Biotech Inc
2024/02/2621:59Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:KRYSKrystal Biotech Inc
2024/02/2621:49Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:KRYSKrystal Biotech Inc
2024/02/2619:57IH Market NewsU.S. Index Futures Dip Amid Inflation Data Anticipation, Oil and Iron Ore Prices RetreatNASDAQ:KRYSKrystal Biotech Inc
2024/02/2021:00GlobeNewswire Inc.Krystal Biotech to Report Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024NASDAQ:KRYSKrystal Biotech Inc
2024/02/1321:00GlobeNewswire Inc.Krystal Biotech Receives FDA Fast Track Designation for Inhaled Oncology Candidate KB707 to Treat Solid Tumors of the LungNASDAQ:KRYSKrystal Biotech Inc
2024/02/0821:00GlobeNewswire Inc.Krystal Biotech Announces Publication in the New England Journal of Medicine on the Application of B-VEC to Treat Ocular Complications in Patient with Dystrophic Epidermolysis BullosaNASDAQ:KRYSKrystal Biotech Inc
2024/02/0121:00GlobeNewswire Inc.Krystal Biotech to Present at Guggenheim 6th Annual Biotechnology ConferenceNASDAQ:KRYSKrystal Biotech Inc
2024/01/2507:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRYSKrystal Biotech Inc
2024/01/2301:43Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:KRYSKrystal Biotech Inc
2024/01/0421:00GlobeNewswire Inc.Krystal Biotech Receives Permanent J-code (J3401) for VYJUVEK®NASDAQ:KRYSKrystal Biotech Inc
 검색 관련기사 보기:NASDAQ:KRYS